Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/1998
08/12/1998EP0857064A1 Stabilised pharmaceutical preparations containing thyroid hormone
08/12/1998EP0857063A1 Compositions and methods for buccal delivery of pharmaceutical agents
08/12/1998EP0857062A2 Method of producing multi-layer medicaments in solid form for oral or rectal administration
08/12/1998EP0857061A1 Solubilisation methods
08/12/1998EP0857060A2 Method and preparations for stabilizing biological materials by drying methods without freezing
08/12/1998EP0857047A1 Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals
08/12/1998EP0857020A1 Wet granulation formulation of a growth hormone secretagogue
08/12/1998EP0825848A4 Novel collagen formulations
08/12/1998EP0751947B1 Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity
08/12/1998EP0748215A4 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
08/12/1998EP0697811A4 Non-hazardous pest control
08/12/1998EP0639071B1 Water-in-oil fluid vaccinal emulsions containing a metabolizable oil
08/12/1998CN1190402A Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
08/12/1998CN1190351A Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with estrogen
08/12/1998CN1190343A Layered tablet for controlled release of active substances
08/12/1998CN1190332A Chronological food bar
08/12/1998CN1190018A Externally used ointment for promoting physical and mental health
08/12/1998CN1190016A Compound cold-preventing nose drops and their preparation
08/12/1998CN1190009A Skin moistening ointment
08/12/1998CN1190008A Tissue regeneration promoting ointment for curing bedsore
08/12/1998CN1190006A Compound red sage injecta and its preparation
08/12/1998CN1190005A Compound Weisukang capsule for gastropathy and its preparation
08/12/1998CN1190002A Vermifuge composition for farm animal
08/12/1998CN1190001A Method and compositions for enhancing skin permeation of drugs using permeation enhancers
08/11/1998US5792795 Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
08/11/1998US5792753 Topical anticarcinogenic agent
08/11/1998US5792643 Cooling an aqueous suspension of virus, saccharide, high-molecular-weight structural additive, an amino acid and buffer and freeze drying maintaining 10% water; gene therapy
08/11/1998US5792507 High surface smoothness and low abrasiveness
08/11/1998US5792478 Tissue injectable composition and method of use
08/11/1998US5792477 Emulsification of two phases; separation; washing; reducing level of residual solvent
08/11/1998US5792476 Sustained release glucocorticoid pharmaceutical composition
08/11/1998US5792475 Lymphatic delivery composition
08/11/1998US5792474 Process for the production of retarded pharmaceutical compositions
08/11/1998US5792473 Organic acid carrier crystal covered with coating of carbonate or bicarbonate partially reacted with acid surface through thin barrier of neutral substance to protect acid sensitive drug in tablet; shelf life, rapid dissolution
08/11/1998US5792472 Subjecting single-phase, homogeneous, liquid crystal, lamellar phase to shearing in shearing cell at constant shear rate
08/11/1998US5792471 Dispensing devices powered by hydrogel
08/11/1998US5792469 Liquid formulation of thermoplastic polymer and organic solvent
08/11/1998US5792451 Oral drug delivery compositions and methods
08/11/1998US5792449 Compositions containing zinc linoleate for the treatment of skin disorders
08/11/1998US5792446 Polymeric biocompatible delivery vehicle comprising strontium and fluoride compounds separately incorporated therein to prevent premature reaction
08/11/1998CA2228704A1 Chewable molded tablet containing medicinally active substances
08/11/1998CA2142294C Granular agent for ruminants
08/11/1998CA2113425C Androgens for stimulating the central nervous system and for treating osteoporosis
08/11/1998CA2065859C Amino acid beta-lyase enzyme inhibitors as deodorants
08/11/1998CA2064160C Use of combinations of gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
08/11/1998CA2029599C Medicaments containing as active substance sulphur-containing carboxylic acids and their use in combating retroviruses
08/06/1998WO1998033827A1 Elastomer treatment process to decrease peroxide levels
08/06/1998WO1998033782A1 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
08/06/1998WO1998033552A1 Electro-release systems, modified electrodes and their use
08/06/1998WO1998033528A2 Induction of b cell tolerance
08/06/1998WO1998033520A1 pH-SENSITIVE LIPOSOMES AND OTHER TYPES OF ENCAPSULATED VACCINES CONTAINING IMMUNOMODULATORS, AND METHODS FOR MAKING AND USING SAME
08/06/1998WO1998033514A1 Freeze-dried composition of bone morphogenetic protein human mp52
08/06/1998WO1998033512A1 Oil-free pharmaceutical compositions containing cyclosporin a
08/06/1998WO1998033489A1 Once daily pharmaceutical tablet having a unitary core
08/06/1998WO1998033488A1 Once daily calcium channel blocker tablet having a delayed release core
08/06/1998WO1998033487A1 Use of microparticles with adsorbed antigen to stimulate immune responses
08/06/1998WO1998033486A1 Microparticles and their use in cancer treatment
08/06/1998WO1998033485A1 Method for removing high boiling solvents from drug formulations by vacuum drying
08/06/1998WO1998033484A1 A method for loading liposomes with ionizable phosphorylated hydrophobic compounds
08/06/1998WO1998033483A1 Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
08/06/1998WO1998033482A1 Pain reducing parenteral liposome formulation
08/06/1998WO1998033481A1 Lipid complexes and liposomes of highly insoluble platinum complexes
08/06/1998WO1998033480A1 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
08/06/1998WO1998033479A1 Haemostatic aerosol composition
08/06/1998WO1998033478A2 Rna- and dna-based active agents in nanoparticles
08/06/1998WO1998033474A1 Use of oil from emu or rhea birds as trans-membrane carriers for delivery of drugs, peptides and vaccines
08/06/1998WO1998024504A3 Device for local administration of solid and semisolid pharmaceutical formulations, sustained-release pharmaceutical formulations for parenteral administration and method of preparation
08/06/1998WO1998024436A3 Gel formulations for topical drug delivery
08/06/1998WO1998020856A3 Microparticles containing active substances, agents containing the same, their use in ultrasound-controlled releasing of active substances as well as the method for their production
08/06/1998WO1998018451A3 Substituted amylose as a matrix for sustained drug release
08/06/1998WO1998017317A3 Process for producing biologically active polymer nanoparticle-nucleic acid conjugates
08/06/1998WO1998010767A3 Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
08/06/1998WO1998002148A3 Pharmaceutical composition
08/06/1998DE19724867C1 Use of emulsifier mixtures in pharmaceutical, cosmetic and shampoo compositions
08/06/1998CA2851502A1 Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
08/06/1998CA2692302A1 Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
08/06/1998CA2279544A1 Induction of b cell tolerance
08/06/1998CA2279259A1 Pain reducing parenteral liposome formulation
08/06/1998CA2278675A1 Hard gelatine capsules containing pharmaceutical compositions substantially free of any oil
08/06/1998CA2226393A1 Water-in-oil emulsions comprising two specific emulsifiers and cosmetic applications
08/05/1998EP0856318A1 Cyanoacrylate compositions comprising an antimicrobial agent
08/05/1998EP0856316A1 Method for solubilizing pyridonecarboxylic acid, solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid
08/05/1998EP0856314A1 Immunosuppressant
08/05/1998EP0856313A1 Controlled absorption diltiazem formulations
08/05/1998EP0856312A1 Use of trospium chloride for the manufacture of a medicament for the treatment of diseases of the bladder
08/05/1998EP0856311A1 Transdermal drug delivery system for the treatment of heart diseases
08/05/1998EP0856310A2 Method for stabilizing acriylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized acrylcarboxylic acid
08/05/1998EP0855919A1 Hormone immunomodulated induction of mucosal immune responses
08/05/1998EP0855914A1 Stable formulations of mhc-peptide complexes
08/05/1998EP0855913A1 Iron dextran formulations
08/05/1998EP0855907A1 Composition for transdermal delivery
08/05/1998EP0855906A1 Insoluble drug delivery
08/05/1998EP0855903A1 Cosmetic composition for the treatment of keratinous materials comprising at least a grafted silicone polymer and at least an aqueous dispersion of insoluble particles of non ionic or cationic polymer
08/05/1998EP0855895A1 Liquid crystal cosmetic composition
08/05/1998EP0762865B1 Method for the preparation of pearls and pearls obtained containing an active ingredient with an undefined melting point
08/05/1998EP0759054B1 Composite pressure sensitive hydrophilic adhesive and method of preparing the same
08/05/1998EP0700294B1 Intramuscular and subcutaneous injection solution for animals
08/05/1998EP0690872B1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
08/05/1998EP0675711B1 Atovaquone pharmaceutical compositions
08/05/1998EP0674510B1 Injectable composition comprising paclitaxel
1 ... 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 2599 2600 2601 2602 2603 2604 2605 2606 2607 2608 2609 ... 2991